Work Here?

Vital Biosciences

Work Here?

Claim Your Company

Website

Vital Biosciences

Work Here?

Claim Your Company

Website

About Vital Biosciences

Simplify's Rating

Why Vital Biosciences is rated

Rated D+ on Competitive Edge

Rated B on Growth Potential

Rated C on Rating Differentiation

Industries

Biotechnology

Healthcare

Company Size

51-200

Company Stage

Early VC

Total Funding

$48M

Headquarters

Mississauga, Canada

Founded

2018

Overview

📈

Significant Headcount Growth

Simplify's Take

What believers are saying

Rising demand for at-home diagnostics boosts Vital's market potential.
AI integration offers Vital a competitive edge in diagnostic accuracy.
Global blood testing market growth aligns with Vital's technological advancements.

What critics are saying

Increased competition from established companies like Abbott and Roche.
Potential regulatory scrutiny due to past industry scandals.
Public skepticism may hinder market adoption of new diagnostics.

What makes Vital Biosciences unique

Vital Biosciences focuses on accessible, rapid blood diagnostics post-Theranos era.
The company integrates AI to enhance diagnostic accuracy and speed.
Vital collaborates with tech giants for cloud-based data management in diagnostics.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$48M

Above

Industry Average

Funded Over

1 Rounds

Early VC funding comparison data is currently unavailable. We're working to provide this information soon!

Early VC Funding Comparison

Coming Soon

Benefits

Competitive compensation and benefits package

Professional Development Budget

Conference Attendance Budget

Growth & Insights and Company News

Headcount

6 month growth

↑ 5%

1 year growth

↑ 5%

2 year growth

↑ 5%

Longevity Technology

Jul 27th, 2023

Vital Biosciences raises $48m for revolutionary blood diagnostic tech

Backers include Sam Altman and Marc Benioff as company seeks to create accessible diagnostics and expedite clinical interventions.

BetaKit

Jul 26th, 2023

Vital Biosciences reveals blood-testing solution

After the bloody mess at Theranos, Vital is among the new wave of startups developing accessible diagnostics.

Bloomberg

Jul 24th, 2023

Sam Altman, Valley VCs Bet $48 Million on Blood-Testing Startup

Years after Theranos, Vital Biosciences wants to prove Silicon Valley really can disrupt blood testing.

Recently Posted Jobs

Senior Rust Application Engineer

Oakville, ON, Canada

Firmware Engineer

Oakville, ON, Canada

System Integration Engineer

Oakville, ON, Canada